Marks Group Wealth Management Inc lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 21.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,302 shares of the medical equipment provider’s stock after selling 2,003 shares during the period. Marks Group Wealth Management Inc’s holdings in Intuitive Surgical were worth $4,136,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in ISRG. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. increased its stake in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares during the period. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the third quarter valued at approximately $30,000. Finally, Laurel Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $31,000. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Stock Performance
Shares of NASDAQ:ISRG opened at $418.58 on Tuesday. The stock has a market capitalization of $148.24 billion, a price-to-earnings ratio of 50.74, a PEG ratio of 3.37 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $396.68 and a 1-year high of $603.88. The company has a 50 day moving average price of $446.24 and a 200 day moving average price of $499.80.
Wall Street Analyst Weigh In
A number of research firms recently commented on ISRG. BTIG Research reiterated a “buy” rating and set a $574.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Piper Sandler reiterated an “overweight” rating and set a $580.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, June 2nd. Evercore lowered their price objective on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a research note on Wednesday, March 11th. Finally, Robert W. Baird raised their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $573.63.
Read Our Latest Analysis on Intuitive Surgical
Insider Activity at Intuitive Surgical
In related news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $446.95, for a total transaction of $178,780.00. Following the completion of the sale, the executive vice president owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. This trade represents a 6.13% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 6,698 shares of company stock worth $2,859,708. 0.60% of the stock is owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
